In various tumour cell lines the peptide bradykinin B2receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist
Author:
Publisher
Wiley
Subject
Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0703764/fullpdf
Reference32 articles.
1. Bradykinin B2 receptor-mediated mitogenactivated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor;ADOMEIT;Mol. Cell. Biol.,1999
2. Novel subtype-selective nonpeptide bradykinin receptor antagonists FR 167344 and FR 173657;ARAMORI;Mol. Pharmacol.,1997
3. Effects of a nonpeptide bradykinin B2 receptor antagonist, FR 167344, on different in vivo animal models of inflammation;ASANO;Br. J. Pharmacol.,1997b
4. The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR 173657;ASANO;Br. J. Pharmacol.,1997a
5. Neuropeptide signal transduction in lung carcinoma: clinical implications of bradykinin and overall heterogeneity;BUNN;Cancer Res.,1992
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 Receptor;Frontiers in Endocrinology;2022-05-26
2. Overexpressed Receptors and Proteins in Lung Cancer;Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer;2019
3. Bradykinin Promotes Cell Proliferation, Migration, Invasion, and Tumor Growth of Gastric Cancer Through ERK Signaling Pathway;Journal of Cellular Biochemistry;2017-07-31
4. Exploiting cancer’s phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy;Oncotarget;2017-06-07
5. Is the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC?;Journal of Thoracic Oncology;2016-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3